
Presentation
2107 Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma
All Publications
Publication Date
12-6-2020
Presented At:
62nd ASH Annual Meeting and Exposition
Content Type
Abstract
Publisher's Site:
View at Publisher Website
Citation Information
Yuliya Linhares. "2107 Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma" (2020) Available at: http://works.bepress.com/yuliya-linhares/35/